These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 38336865)

  • 1. Microstructural integrity of the locus coeruleus and its tracts reflect noradrenergic degeneration in Alzheimer's disease and Parkinson's disease.
    Lin CP; Frigerio I; Bol JGJM; Bouwman MMA; Wesseling AJ; Dahl MJ; Rozemuller AJM; van der Werf YD; Pouwels PJW; van de Berg WDJ; Jonkman LE
    Transl Neurodegener; 2024 Feb; 13(1):9. PubMed ID: 38336865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease.
    McMillan PJ; White SS; Franklin A; Greenup JL; Leverenz JB; Raskind MA; Szot P
    Brain Res; 2011 Feb; 1373():240-52. PubMed ID: 21147074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nigral Pathology Contributes to Microstructural Integrity of Striatal and Frontal Tracts in Parkinson's Disease.
    Lin CP; Knoop LEJ; Frigerio I; Bol JGJM; Rozemuller AJM; Berendse HW; Pouwels PJW; van de Berg WDJ; Jonkman LE
    Mov Disord; 2023 Sep; 38(9):1655-1667. PubMed ID: 37347552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noradrenergic pathways of locus coeruleus in Parkinson's and Alzheimer's pathology.
    Singh S
    Int J Neurosci; 2020 Mar; 130(3):251-261. PubMed ID: 31575316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locus Coeruleus Degeneration Induces Forebrain Vascular Pathology in a Transgenic Rat Model of Alzheimer's Disease.
    Kelly SC; McKay EC; Beck JS; Collier TJ; Dorrance AM; Counts SE
    J Alzheimers Dis; 2019; 70(2):371-388. PubMed ID: 31177220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic Mice Expressing Human α-Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson's Disease.
    Butkovich LM; Houser MC; Chalermpalanupap T; Porter-Stransky KA; Iannitelli AF; Boles JS; Lloyd GM; Coomes AS; Eidson LN; De Sousa Rodrigues ME; Oliver DL; Kelly SD; Chang J; Bengoa-Vergniory N; Wade-Martins R; Giasson BI; Joers V; Weinshenker D; Tansey MG
    J Neurosci; 2020 Sep; 40(39):7559-7576. PubMed ID: 32868457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Locus Coeruleus Integrity Is Linked to Response Inhibition Deficits in Parkinson's Disease and Progressive Supranuclear Palsy.
    Ye R; Hezemans FH; O'Callaghan C; Tsvetanov KA; Rua C; Jones PS; Holland N; Malpetti M; Murley AG; Barker RA; Williams-Gray CH; Robbins TW; Passamonti L; Rowe JB
    J Neurosci; 2023 Oct; 43(42):7028-7040. PubMed ID: 37669861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases.
    Zarow C; Lyness SA; Mortimer JA; Chui HC
    Arch Neurol; 2003 Mar; 60(3):337-41. PubMed ID: 12633144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noradrenergic neuromodulation in ageing and disease.
    Krohn F; Lancini E; Ludwig M; Leiman M; Guruprasath G; Haag L; Panczyszyn J; Düzel E; Hämmerer D; Betts M
    Neurosci Biobehav Rev; 2023 Sep; 152():105311. PubMed ID: 37437752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson's disease.
    Doppler CEJ; Kinnerup MB; Brune C; Farrher E; Betts M; Fedorova TD; Schaldemose JL; Knudsen K; Ismail R; Seger AD; Hansen AK; Stær K; Fink GR; Brooks DJ; Nahimi A; Borghammer P; Sommerauer M
    Brain; 2021 Oct; 144(9):2732-2744. PubMed ID: 34196700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Role of Locus Coeruleus in Alzheimer's Disease: a Comprehensive Update on MRI Studies and Implications.
    Galgani A; Giorgi FS
    Curr Neurol Neurosci Rep; 2023 Dec; 23(12):925-936. PubMed ID: 38064152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging of noradrenergic neurons.
    Watanabe T; Tan Z; Wang X; Martinez-Hernandez A; Frahm J
    Brain Struct Funct; 2019 May; 224(4):1609-1625. PubMed ID: 30903359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locus Coeruleus Integrity from 7 T MRI Relates to Apathy and Cognition in Parkinsonian Disorders.
    Ye R; O'Callaghan C; Rua C; Hezemans FH; Holland N; Malpetti M; Jones PS; Barker RA; Williams-Gray CH; Robbins TW; Passamonti L; Rowe J
    Mov Disord; 2022 Aug; 37(8):1663-1672. PubMed ID: 35576973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurogenic orthostatic hypotension in Parkinson's disease: is there a role for locus coeruleus magnetic resonance imaging?
    Palermo G; Galgani A; Bellini G; Lombardo F; Martini N; Morganti R; Paoli D; De Cori S; Frijia F; Siciliano G; Ceravolo R; Giorgi FS
    J Neural Transm (Vienna); 2024 Feb; 131(2):157-164. PubMed ID: 38032367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noradrenergic Dysfunction in Alzheimer's and Parkinson's Diseases-An Overview of Imaging Studies.
    Peterson AC; Li CR
    Front Aging Neurosci; 2018; 10():127. PubMed ID: 29765316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractional anisotropy changes in Alzheimer's disease depend on the underlying fiber tract architecture: a multiparametric DTI study using joint independent component analysis.
    Teipel SJ; Grothe MJ; Filippi M; Fellgiebel A; Dyrba M; Frisoni GB; Meindl T; Bokde AL; Hampel H; Klöppel S; Hauenstein K;
    J Alzheimers Dis; 2014; 41(1):69-83. PubMed ID: 24577476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Widespread Reduced Density of Noradrenergic Locus Coeruleus Axons in the App Knock-In Mouse Model of Amyloid-β Amyloidosis.
    Sakakibara Y; Hirota Y; Ibaraki K; Takei K; Chikamatsu S; Tsubokawa Y; Saito T; Saido TC; Sekiya M; Iijima KM
    J Alzheimers Dis; 2021; 82(4):1513-1530. PubMed ID: 34180416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common factors among Alzheimer's disease, Parkinson's disease, and epilepsy: possible role of the noradrenergic nervous system.
    Szot P
    Epilepsia; 2012 Jun; 53 Suppl 1():61-6. PubMed ID: 22612810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive analysis of the effect of DSP4 on the locus coeruleus noradrenergic system in the rat.
    Szot P; Miguelez C; White SS; Franklin A; Sikkema C; Wilkinson CW; Ugedo L; Raskind MA
    Neuroscience; 2010 Mar; 166(1):279-91. PubMed ID: 20045445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Neurotoxin DSP-4 Dysregulates the Locus Coeruleus-Norepinephrine System and Recapitulates Molecular and Behavioral Aspects of Prodromal Neurodegenerative Disease.
    Iannitelli AF; Kelberman MA; Lustberg DJ; Korukonda A; McCann KE; Mulvey B; Segal A; Liles LC; Sloan SA; Dougherty JD; Weinshenker D
    eNeuro; 2023 Jan; 10(1):. PubMed ID: 36635251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.